Novobion is a discovery and development company with primary focus on therapeutic solutions for organ transplant preservation. Novobion has developed a novel drug delivery system, which enables efficient targeting of tissues and organs currently inaccessible to effective therapies. The delivery system is based on ingredients with proven safety record thus minimizing the risk of adverse effects in clinical use. Novobion has filed extensive patent protection on the novel drug carrier system, formulations based on the carrier system and their therapeutic uses.